Cartilage matrix degradation pathways

Cartilage matrix degradation pathways represent the coordinated biological processes responsible for the breakdown of the extracellular matrix (ECM) in articular cartilage, primarily involving the proteolysis of type II collagen and aggrecan [1, 2]. These pathways are driven by key catabolic enzymes, most notably matrix metalloproteinases (MMPs) like MMP-13 and a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) such as ADAMTS-4 and ADAMTS-5 [1, 2]. In healthy joints, a balance exists between matrix synthesis and degradation; however, in diseases like osteoarthritis (OA) and rheumatoid arthritis (RA), pro-inflammatory cytokines (e.g., IL-1β, TNF-α) and mechanical stress shift this balance toward excessive catabolism [1, 3]. Therapeutic strategies, known as disease-modifying osteoarthritis drugs (DMOADs), target these pathways by inhibiting specific proteases, modulating signaling cascades like Wnt or NF-κB, or promoting anabolic repair through growth factors [4, 6]. Despite significant research, targeting these pathways remains challenging due to the irreversible nature of collagen loss and the need for localized drug delivery to avoid systemic side effects [5, 6]. Sources: [1] MDPI, 2022 (https://www.mdpi.com/1422-0067/23/21/13163) [2] NIH/PMC, 2010 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2852046/) [3] NIH/PMC, 2002 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC128930/) [4] NIH/PMC, 2021 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618648/) [5] MDPI, 2022 (https://www.mdpi.com/2075-4418/12/11/2718) [6] Open Access Journals, 2010 (https://www.openaccessjournals.com/articles/is-cartilage-matrix-breakdown-an-appropriate-therapeutic-target-in-osteoarthritis--insights-from-studies-of-aggrecan-and-collagen-proteolysis.pdf)

Other names

Cartilage matrix catabolismExtracellular matrix degradationChondrocyte-mediated matrix degradationArticular cartilage breakdown

Inhibition of matrix-degrading enzymes such as collagenases (MMPs) and aggrecanases (ADAMTS), modulation of pro-inflammatory signaling pathways (e.g., Wnt, NF-κB), and stimulation of anabolic cartilage repair through growth factor analogs.